Christopher D. Hillyer, MD
President and CEO of New York Blood Center (NYBC)
New York Blood Center has been instrumental in developing responses to MERS, SARS, EBOLA, HIV, West NIle Virus, and African Swine Fever. Through its nimble structures, NYBC is able to leverage diverse researchers and innovative approaches in real time.
Dr. Hillyer will speak on developing vaccines, therapies, and surveillance.
He serves as Professor, Department of Medicine, Weill Cornell Medical College, New York, New York. He was previously the tenured, endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine. He is a co-founder of the Transfusion & Transplantation Technologies, Inc. (3Ti), and HemeXcel, and holds a number of patents related to transfusion medicine and cellular therapies.